ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
Share Facebook Twitter LinkedIn Pinterest Email Click HereJLABS@NYC IncubatorSBIR Impact NYC ProgramELABNYCBioBatNewYorkBioHarlem BiospaceAlexandria LaunchLabsLifeSci NYCAuthor Biotech Metropolitan Women
